Trial Profile
Phase I, open-label, randomised, 2-arm drug interaction study evaluating the effects of atorvastatin and ethinylestradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Lomitapide (Primary) ; Atorvastatin; Ethinylestradiol/norgestimate
- Indications Hyperlipoproteinaemia type IIa
- Focus Pharmacokinetics
- 05 Nov 2015 New trial record